一例DMD基因Alu元件插入突变导致杜氏肌营养不良及其白发症状分析
收稿日期: 2024-04-17
修回日期: 2024-05-31
网络出版日期: 2024-06-03
基金资助
山东省自然科学基金面上项目(ZR2023MH186);中央引导地方科技发展资金项目(YDZX2022008);滨州市农社领域科技创新政策引导计划项目(2023SHFZ036);滨州市农社领域科技创新政策引导计划项目(2023SHFZ037)
A case study of Duchenne muscular dystrophy caused by Alu element insertion in DMD gene and analysis of its gray-hair symptoms
Received date: 2024-04-17
Revised date: 2024-05-31
Online published: 2024-06-03
Supported by
Shandong Provincial Natural Science Foundation Project(ZR2023MH186);Shandong Provincial Central Guide Local Science and Technology Development Fund Project(YDZX2022008);Binzhou Municipal Agricultural Community Science and Technology Innovation Policy Guidance Program(2023SHFZ036);Binzhou Municipal Agricultural Community Science and Technology Innovation Policy Guidance Program(2023SHFZ037)
杜氏肌营养不良(Duchenne muscular dystrophy,DMD)是由DMD基因突变引起的抗肌萎缩蛋白缺乏的一种严重X连锁隐性遗传病,突变形式主要包括外显子缺失和重复、点突变、插入突变等,这些突变通过不同方式影响了抗肌萎缩蛋白的正常表达,最终导致疾病的发生。本研究报告了1例DMD基因第59号外显子(exon 59,E59)插入突变引起的DMD,该患儿相关生化指标明显异常,表现较为明显的DMD早期症状,并出现了多处白发。其母亲和姐姐为携带者,生化指标轻微异常,母亲有轻微临床症状,姐姐无临床症状。其他成员基因和身体状况正常。经测序和序列比对发现,该插入片段为AluYa5亚家族的Alu元件,该片段插入可产生两个终止密码子,末端含一段多聚腺苷酸尾(polyA)。为了解该插入突变对于DMD基因的影响以及与临床症状的关联,通过外显子剪接增强子(exonic splicing enhancer,ESE)预测发现,该插入并不影响E59的剪接,由此推测该插入序列会最终出现在DMD基因的mRNA序列中,插入序列中的2个终止子和polyA很可能会在翻译过程中发挥终止作用,不能产生有功能的抗肌萎缩蛋白,这可能是导致DMD发生的机制。另外该患儿除了典型的DMD症状外,还出现了过早白发症状。本研究首次报道了1例DMD基因编码区插入Alu元件导致的DMD,为研究Alu序列逆转座引发基因突变提供线索,同时扩展了对DMD基因突变的认识。
李慧, 张如意, 李长叶, 张肖林, 郑庆印, 刘秀珍 . 一例DMD基因Alu元件插入突变导致杜氏肌营养不良及其白发症状分析[J]. 遗传, 2024 , 46(7) : 570 -580 . DOI: 10.16288/j.yczz.24-020
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive genetic disorder caused by mutations in the DMD gene, which leads to a deficiency of the dystrophin protein. The main mutation types of this gene include exon deletions and duplications, point mutations, and insertions. These mutations disrupt the normal expression of dystrophin, ultimately leading to the disease. In this study, we reported a case of DMD caused by an insertion mutation in exon 59 (E59) of the DMD gene. The affected child exhibited significant abnormalities in related biochemical markers, early symptoms of DMD, and multiple gray hair. His mother and sister were carriers with slightly abnormal biochemical markers. The mother had mild clinical symptoms, while the sister had no clinical symptoms. Other family members were genetically and physically normal. Sequencing and sequence alignment revealed that the inserted fragment was an Alu element from the AluYa5 subfamily. This insertion produced two stop codons and a polyadenylate (polyA) tail. To understand the impact of this insertion on the DMD gene and its association with clinical symptoms, exonic splicing enhancer (ESE) prediction indicated that the insertion did not affect the splicing of E59. Therefore, we speculated that the insertion sequence would be present in the mRNA sequence of the DMD gene. The two stop codons and polyA tail likely terminate translation, preventing the production of functional dystrophin protein, which may be the mechanism leading to DMD. In addition to typical DMD symptoms, the child also exhibited premature graying of hair. This study reports, for the first time, a case of DMD caused by the insertion of an Alu element into the coding region of the DMD gene. This finding provides clues for studying gene mutations induced by Alu sequence insertion and expands the understanding of DMD gene mutations.
Key words: Duchenne muscular dystrophy; DMD; Alu element; insertion mutation; gray hair
| [1] | Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51(6): 919-928. |
| [2] | Mercuri E, B?nnemann CG, Muntoni F. Muscular dystrophies. Lancet, 2019, 394(10213): 2025-2038. |
| [3] | Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, Ortez C, Baiget M, Gallano P. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS One, 2015, 10(8): e0135189. |
| [4] | Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, Jain M, Kleijnen J. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis, 2017, 12(1): 79. |
| [5] | Kamdar F, Garry DJ. Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol, 2016, 67(21): 2533-2546. |
| [6] | Li SY, Sun XF, Li Q, Zhang HM, Wang XM. Association of mutation types and distribution characteristics of dystrophin gene with clinical symptoms in Chinese population. Hereditas(Beijing), 2011, 33(3): 251-254. |
| 李少英, 孙筱放, 黎青, 张慧敏, 王晓蔓. 中国人群中抗肌萎缩蛋白基因突变类型和分布特点及其与临床症状的相关性. 遗传, 2011, 33(3): 251-254. | |
| [7] | Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord, 2001, 11(2): 186-191. |
| [8] | Ma PP, Dong YL, Wu SW. Relationship between cognitive function and Dp140 expression in children with Duchenne muscular dystrophy. Med J Chin PLA, 2018, 43(11): 950-955. |
| 马沛沛, 董玉茹, 吴士文. Duchenne型肌营养不良患儿认知功能特点及与Dp140表达的关系. 解放军医学杂志, 2018, 43(11): 950-955. | |
| [9] | Ayarpadikannan S, Lee HE, Han K, Kim HS. Transposable element-driven transcript diversification and its relevance to genetic disorders. Gene, 2015, 558(2): 187-194. |
| [10] | El-Sheikh AM, Elfar NN, Mourad HA, Hewedy ESS. Relationship between trace elements and premature hair graying. Int J Trichology, 2018, 10(6): 278-283. |
| [11] | Kumar AB, Shamim H, Nagaraju U. Premature graying of hair: review with updates. Int J Trichology, 2018, 10(5): 198-203. |
| [12] | Baxter LL, Watkins-Chow DE, Pavan WJ, Loftus SK. A curated gene list for expanding the horizons of pigmentation biology. Pigment Cell Melanoma Res, 2019, 32(3): 348-358. |
| [13] | Tyers L, Davids LM, Wilmshurst JM, Esterhuizen AI. Skin cells for use in an alternate diagnostic method for Duchenne muscular dystrophy. Neuromuscul Disord, 2018, 28(7): 553-563. |
| [14] | Tanveer N, Sharma MC, Sarkar C, Gulati S, Kalra V, Singh S, Bhatia R. Diagnostic utility of skin biopsy in dystrophinopathies. Clin Neurol Neurosurg, 2009, 111(6): 496-502. |
| [15] | Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab, 1999, 67(3): 183-193. |
| [16] | Carroll ML, Roy-Engel AM, Nguyen SV, Salem AH, Vogel E, Vincent B, Myers J, Ahmad Z, Nguyen L, Sammarco M, Watkins WS, Henke J, Makalowski W, Jorde LB, Deininger PL, Batzer MA. Large-scale analysis of the Alu Ya5 and Yb8 subfamilies and their contribution to human genomic diversity. J Mol Biol, 2001, 311(1): 17-40. |
| [17] | Otieno AC, Carter AB, Hedges DJ, Walker JA, Ray DA, Garber RK, Anders BA, Stoilova N, Laborde ME, Fowlkes JD, Huang CH, Perodeau B, Batzer MA. Analysis of the human Alu Ya-lineage. J Mol Biol, 2004, 342(1): 109-118. |
| [18] | Comeaux MS, Roy-Engel AM, Hedges DJ, Deininger PL. Diverse cis factors controlling Alu retrotransposition: what causes Alu elements to die?. Genome Res, 2009, 19(4): 545-555. |
| [19] | Perez-Stable C, Ayres TM, Shen CK. Distinctive sequence organization and functional programming of an Alu repeat promoter. Proc Natl Acad Sci USA, 1984, 81(17): 5291-5295. |
| [20] | Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA, 1997, 94(5): 1872-1877. |
| [21] | Hancks DC, Kazazian HH. Roles for retrotransposon insertions in human disease. Mob DNA, 2016, 7: 9. |
| [22] | Roy-Engel AM, Salem AH, Oyeniran OO, Deininger L, Hedges DJ, Kilroy GE, Batzer MA, Deininger PL. Active Alu element "A-tails": size does matter. Genome Res, 2002, 12(9): 1333-1344. |
| [23] | Dewannieux M, Heidmann T. Role of poly(A) tail length in Alu retrotransposition. Genomics, 2005, 86(3): 378-381. |
| [24] | Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet, 2002, 3(5): 370-379. |
| [25] | Ferlini A, Galié N, Merlini L, Sewry C, Branzi A, Muntoni F. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet, 1998, 63(2): 436-446. |
| [26] | Torella A, Budillon A, Zanobio M, Del Vecchio Blanco F, Picillo E, Politano L, Nigro V, Piluso G. Alu-mediated insertions in the DMD gene: a difficult puzzle to interpret clinically. Int J Mol Sci, 2023, 24(11): 9241. |
| [27] | Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Howard MT, Sampson JB, Swoboda KJ, Bromberg MB, Mendell JR, Taylor LE, Anderson CB, Pestronk A, Florence JM, Connolly AM, Mathews KD, Wong B, Finkel RS, Bonnemann CG, Day JW, McDonald C, United Dystrophinopathy Project Consortium, Weiss RB. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat, 2011, 32(3): 299-308. |
| [28] | Bello L, Pegoraro E. Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy. Acta Myol, 2016, 35(3): 122-127. |
| [29] | Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 1988, 2(1): 90-95. |
| [30] | Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve, 2006, 34(2): 135-144. |
| [31] | Okubo M, Noguchi S, Hayashi S, Nakamura H, Komaki H, Matsuo M, Nishino I. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy. Hum Genet, 2020, 139(2): 247-255. |
| [32] | Pellegrini C, Zulian A, Gualandi F, Manzati E, Merlini L, Michelini ME, Benassi L, Marmiroli S, Ferlini A, Sabatelli P, Bernardi P, Maraldi NM. Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy. J Cell Physiol, 2013, 228(6): 1323-1231. |
| [33] | K?rner H, Epanchintsev A, Berking C, Schuler-Thurner B, Speicher MR, Menssen A, Hermeking H. Digital karyotyping reveals frequent inactivation of the dystrophin/ DMD gene in malignant melanoma. Cell Cycle, 2007, 6(2): 189-198. |
/
| 〈 |
|
〉 |